Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 12 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2020 Filed Mar 17, 2020 20:13 UTC |
Morley StephaniePresident and COO
|
GrantStock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001790 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Shares, without par value · 750,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
Rowe Jeffrey MDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001787 · ownership.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares, without par value · 250,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Williams Rodney JamesDirector
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001785 · ownership.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares, without par value · 200,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:02 UTC |
Morley StephaniePresident & COO
|
GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001171843-19-005969 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Shares, without par value · 500,000 shares Expires 2021-09-16 F1 · derivative.exercise_date: The options vested upon grant and are currently fully vested. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 22:22 UTC |
POWERS JOHNNY DDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-19-000712 · ownership.xml · derivative · entry 1 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Shares, without par value · 1,000,000 shares Expires 2021-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On August 16, 2019, the Issuer granted to Dr. Powers stock options to acquire up to an aggregate of 1,000,000 common shares of the Issuer pursuant to the Issuer's stock option plan. All of the stock options are fully vested and are exercisable for a period of two years from the date of grant. 500,000 of the stock options are exercisable at a price of US$0.26 per share, 100,000 of the stock options are exercisable at a price of US$0.35 per share, 100,000 of the stock options are exercisable at a price of US$0.45 per share, 100,000 of the stock options are exercisable at a price of US$0.55 per share, 100,000 of the stock options are exercisable at a price of US$0.65 per share and 100,000 of the stock options are exercisable at a price of US$0.75 per share. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 16:01 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 65,789 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-002177 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,705,265 Underlying: Common Shares, without par value · 65,789 shares Expires 2021-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 16:01 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionCommon Shares, without par value | 65,789 | $1.52 | $99,999.28 |
DisclosureSEC source: 0001171843-19-002177 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,545,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 16:01 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 164,473 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-001790 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,771,054 Underlying: Common Shares, without par value · 164,473 shares Expires 2021-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 16:01 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionCommon Shares, without par value | 164,473 | $1.52 | $249,998.96 |
DisclosureSEC source: 0001171843-19-001790 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,479,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 16:06 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 164,473 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-001650 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,935,527 Underlying: Common Shares, without par value · 164,473 shares Expires 2021-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 16:06 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionCommon Shares, without par value | 164,473 | $1.52 | $249,998.96 |
DisclosureSEC source: 0001171843-19-001650 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,315,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 16:15 UTC |
LeBar JamesDirector
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000266 · ownership.xml · derivative · entry 1 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Shares, without par value · 400,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 16:12 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 2,100,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000263 · ownership.xml · derivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100,000 Underlying: Common Shares, without par value · 2,100,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 16:08 UTC |
Herbst BrukChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000259 · ownership.xml · derivative · entry 1 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Shares, without par value · 300,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 16:10 UTC |
Shameze RampertabDirector · Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 950,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000261 · ownership.xml · derivative · entry 1 Shameze Rampertab · CIK 0001721810 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,000 Underlying: Common Shares, without par value · 950,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:13 UTC |
Williams Rodney JamesDirector
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000264 · ownership.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Shares, without par value · 400,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:11 UTC |
Rowe Jeffrey MDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 350,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000262 · ownership.xml · derivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Shares, without par value · 350,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:10 UTC |
Morley StephanieCOO & VP of Product Dev
|
GrantStock Option (right to buy) · Derivative | 900,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000260 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Shares, without par value · 900,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| December 20, 2018 Filed Dec 28, 2018 00:01 UTC |
Williams Rodney JamesDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-18-001001 · zomedica_form4dec202018.xml · derivative · entry 3 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 200,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. Read SEC document |
| December 20, 2018 Filed Dec 28, 2018 00:01 UTC |
Williams Rodney JamesDirector
|
Exercise / conversionCommon Shares, without par value | 26,900 | $1.20 | $32,280.00 |
DisclosureSEC source: 0000905718-18-001001 · zomedica_form4dec202018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 22:48 UTC |
Rowe Jeffrey MDirector · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000960 · rowe-zomed_fm4nov292018.xml · derivative · entry 5 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 175,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 22:48 UTC |
Rowe Jeffrey MDirector · 10% owner
|
Exercise / conversionCommon Shares, without par value | 175,000 | $1.20 | $210,000.00 |
DisclosureSEC source: 0000905718-18-000960 · rowe-zomed_fm4nov292018.xml · nonDerivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2018 Filed Oct 12, 2018 18:56 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000845 · ownership.xml · derivative · entry 2 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 200,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. Read SEC document |
| October 11, 2018 Filed Oct 12, 2018 18:56 UTC |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
Exercise / conversionCommon Shares, without par value | 200,000 | $1.20 | $240,000.00 |
DisclosureSEC source: 0000905718-18-000845 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,151,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2018 Filed Mar 12, 2019 16:03 UTC Amendment |
Solensky Gerald JRDirector · President and CEO · 10% owner
|
SaleCommon Shares, without par value | 164 | $1.89 | $309.96 |
DisclosureSEC source: 0001171843-19-001649 · ownership.xml · nonDerivative · entry 1 Solensky Gerald JR · CIK 0001721759 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,950,936 F1 · date: The transfer of 164 Common Shares to SEI Private Trust Company on October 2, 2018 was inadvertently omitted from the Form 4 filed by Reporting Person on October 12, 2018. The 164 Common Shares were transferred without Reporting Person's consent and the transfer is currently being contested by Reporting Person. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 16:14 UTC |
LeBar JamesDirector
|
SaleCommon Shares, without par value | 200,000 | $2.15 | $430,000.00 |
DisclosureSEC source: 0000905718-18-000775 · zomedica_form4aug282018.xml · nonDerivative · entry 1 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 21:50 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 1,000 | $1.92 | $1,920.00 |
DisclosureSEC source: 0000905718-18-000563 · zomedica_form4jun112018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:35 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 500 | $1.93 | $965.00 |
DisclosureSEC source: 0000905718-18-000552 · zomedica_form4may312018.xml · nonDerivative · entry 2 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:35 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 1,500 | $1.91 | $2,865.00 |
DisclosureSEC source: 0000905718-18-000552 · zomedica_form4may312018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,500 Read SEC document |
| May 24, 2018 Filed May 29, 2018 20:07 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 500 | $1.92 | $960.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 7 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Read SEC document |
| May 23, 2018 Filed May 29, 2018 20:07 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 12 | $1.95 | $23.40 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 6 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,500 Read SEC document |
| May 23, 2018 Filed May 29, 2018 20:07 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 88 | $1.91 | $168.08 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 5 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,512 Read SEC document |
| May 23, 2018 Filed May 29, 2018 20:07 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 400 | $1.92 | $768.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 4 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,600 Read SEC document |
| May 22, 2018 Filed May 29, 2018 20:07 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 500 | $1.93 | $965.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 3 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,000 Read SEC document |
| May 21, 2018 Filed May 29, 2018 20:07 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 400 | $2.00 | $800.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 2 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,500 Read SEC document |
| May 21, 2018 Filed May 29, 2018 20:07 UTC |
Williams Rodney JamesDirector
|
SaleCommon Shares, without par value | 100 | $2.03 | $203.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,900 Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 22:36 UTC |
Morley StephanieCOO & VP of Product Dev
|
Exercise / conversionStock Option (right to buy) · Derivative | 104,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000403 · zomedica_form4apr202018.xml · derivative · entry 7 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 104,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 22:36 UTC |
Morley StephanieCOO & VP of Product Dev
|
Exercise / conversionCommon Shares, without par value | 104,000 | $0.20 | $20,800.00 |
DisclosureSEC source: 0000905718-18-000403 · zomedica_form4apr202018.xml · nonDerivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 16:04 UTC |
Herbst BrukChief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 62,996 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000353 · zomedica_form4mar292018.xml · derivative · entry 5 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,004 Underlying: Common Shares, without par value · 62,996 shares Expires 2019-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 16:04 UTC |
Herbst BrukChief Commercial Officer
|
Exercise / conversionCommon Shares, without par value | 62,996 | $2.20 | $138,591.20 |
DisclosureSEC source: 0000905718-18-000353 · zomedica_form4mar292018.xml · nonDerivative · entry 1 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 20:08 UTC |
Morley StephanieCOO & VP of Product Dev
|
Exercise / conversionStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000355 · zomedica_form4mar292018.xml · derivative · entry 7 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Shares, without par value · 500,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 20:08 UTC |
Morley StephanieCOO & VP of Product Dev
|
Exercise / conversionCommon Shares, without par value | 500,000 | $0.20 | $100,000.00 |
DisclosureSEC source: 0000905718-18-000355 · zomedica_form4mar292018.xml · nonDerivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Apr 17, 2018 21:08 UTC Amendment |
Morley StephanieCOO & VP of Product Dev
|
Exercise / conversionStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000399 · zomedica_form4ammar302018.xml · derivative · entry 2 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 500,000 shares Expires 2019-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This amendment is being filed to correctly state the stock options that were exercised. The options that were exercised were misstated on Stephanie Morley's ("Reporting Person") original Form 4 filed with the Securities Exchange Commission on March 30, 2018. Reporting Person exercised 500,000 options at an exercise price of $2.20 per share. Reporting Person continues to hold 1,100,000 options exercisable at $0.20 per share which were granted on March 28, 2016. F2 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 29, 2018 Filed Apr 17, 2018 21:08 UTC Amendment |
Morley StephanieCOO & VP of Product Dev
|
Exercise / conversionCommon Shares, without par value | 500,000 | $2.20 | $1,100,000.00 |
DisclosureSEC source: 0000905718-18-000399 · zomedica_form4ammar302018.xml · nonDerivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This amendment is being filed to correctly state the stock options that were exercised. The options that were exercised were misstated on Stephanie Morley's ("Reporting Person") original Form 4 filed with the Securities Exchange Commission on March 30, 2018. Reporting Person exercised 500,000 options at an exercise price of $2.20 per share. Reporting Person continues to hold 1,100,000 options exercisable at $0.20 per share which were granted on March 28, 2016. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:53 UTC |
Rowe Jeffrey MDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000334 · zomedica_form4mar232018.xml · derivative · entry 5 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 100,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:53 UTC |
Rowe Jeffrey MDirector
|
Exercise / conversionCommon Shares, without par value | 100,000 | $0.20 | $20,000.00 |
DisclosureSEC source: 0000905718-18-000334 · zomedica_form4mar232018.xml · nonDerivative · entry 1 Rowe Jeffrey M · CIK 0001619009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:46 UTC |
Williams Rodney JamesDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000332 · zomedica_form4mar232018.xml · derivative · entry 3 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 140,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:46 UTC |
Williams Rodney JamesDirector
|
Exercise / conversionCommon Shares, without par value | 140,000 | $0.20 | $28,000.00 |
DisclosureSEC source: 0000905718-18-000332 · zomedica_form4mar232018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2018 Filed Mar 19, 2018 16:14 UTC |
Shameze RampertabDirector · Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 176,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000320 · rampertab_form4mar192018.xml · derivative · entry 5 Shameze Rampertab · CIK 0001721810 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 176,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 12, 2018 Filed Mar 19, 2018 16:14 UTC |
Shameze RampertabDirector · Chief Financial Officer
|
Exercise / conversionCommon Shares, without par value | 176,000 | $0.20 | $35,200.00 |
DisclosureSEC source: 0000905718-18-000320 · rampertab_form4mar192018.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.